Cargando…

Evaluation of blood lead level in methamphetamine users in Tehran

BACKGROUND: Given the increasing number of lead poisoning in opioids users and since no study has been conducted so far to review lead poisoning in methamphetamine (crystal) users, this study aimed to investigate blood lead level in methamphetamine addicts. METHODS: This study was conducted on 20 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mostafazadeh, Babak, Shadnia, Shahin, Tavakkoli, Mohammad Ali, Khoddami Vishteh, Hamid Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320762/
https://www.ncbi.nlm.nih.gov/pubmed/28222753
http://dx.doi.org/10.1186/s13011-017-0088-3
_version_ 1782509601047969792
author Mostafazadeh, Babak
Shadnia, Shahin
Tavakkoli, Mohammad Ali
Khoddami Vishteh, Hamid Reza
author_facet Mostafazadeh, Babak
Shadnia, Shahin
Tavakkoli, Mohammad Ali
Khoddami Vishteh, Hamid Reza
author_sort Mostafazadeh, Babak
collection PubMed
description BACKGROUND: Given the increasing number of lead poisoning in opioids users and since no study has been conducted so far to review lead poisoning in methamphetamine (crystal) users, this study aimed to investigate blood lead level in methamphetamine addicts. METHODS: This study was conducted on 20 patients with methamphetamine poisoning and their blood lead level was measured. The subjects were selected from among patients with a history of continuous use of methamphetamine, without a history of using opiates in the past 6 months confirmed by a negative urine tests, and without a history of heavy metal poisoning. RESULTS: Of all, 18 patients were male and the mean age was 32 ± 10 years; 17 patients were abusing the drug via inhalation and three persons via oral administration. The mean blood lead level was 2.3 ± 1.1 μg/dL and poisoning was not observed in any of the cases. Blood lead level was not associated with age, sex, dosage, and route of administration. CONCLUSION: Although blood lead level was not at poisoning level in people who only used methamphetamine in Iran, due to the simultaneous use of other substances and because of non-specific symptoms, lead poisoning must be suspected in all cases of substances poisoning.
format Online
Article
Text
id pubmed-5320762
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53207622017-02-24 Evaluation of blood lead level in methamphetamine users in Tehran Mostafazadeh, Babak Shadnia, Shahin Tavakkoli, Mohammad Ali Khoddami Vishteh, Hamid Reza Subst Abuse Treat Prev Policy Research BACKGROUND: Given the increasing number of lead poisoning in opioids users and since no study has been conducted so far to review lead poisoning in methamphetamine (crystal) users, this study aimed to investigate blood lead level in methamphetamine addicts. METHODS: This study was conducted on 20 patients with methamphetamine poisoning and their blood lead level was measured. The subjects were selected from among patients with a history of continuous use of methamphetamine, without a history of using opiates in the past 6 months confirmed by a negative urine tests, and without a history of heavy metal poisoning. RESULTS: Of all, 18 patients were male and the mean age was 32 ± 10 years; 17 patients were abusing the drug via inhalation and three persons via oral administration. The mean blood lead level was 2.3 ± 1.1 μg/dL and poisoning was not observed in any of the cases. Blood lead level was not associated with age, sex, dosage, and route of administration. CONCLUSION: Although blood lead level was not at poisoning level in people who only used methamphetamine in Iran, due to the simultaneous use of other substances and because of non-specific symptoms, lead poisoning must be suspected in all cases of substances poisoning. BioMed Central 2017-02-22 /pmc/articles/PMC5320762/ /pubmed/28222753 http://dx.doi.org/10.1186/s13011-017-0088-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mostafazadeh, Babak
Shadnia, Shahin
Tavakkoli, Mohammad Ali
Khoddami Vishteh, Hamid Reza
Evaluation of blood lead level in methamphetamine users in Tehran
title Evaluation of blood lead level in methamphetamine users in Tehran
title_full Evaluation of blood lead level in methamphetamine users in Tehran
title_fullStr Evaluation of blood lead level in methamphetamine users in Tehran
title_full_unstemmed Evaluation of blood lead level in methamphetamine users in Tehran
title_short Evaluation of blood lead level in methamphetamine users in Tehran
title_sort evaluation of blood lead level in methamphetamine users in tehran
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320762/
https://www.ncbi.nlm.nih.gov/pubmed/28222753
http://dx.doi.org/10.1186/s13011-017-0088-3
work_keys_str_mv AT mostafazadehbabak evaluationofbloodleadlevelinmethamphetamineusersintehran
AT shadniashahin evaluationofbloodleadlevelinmethamphetamineusersintehran
AT tavakkolimohammadali evaluationofbloodleadlevelinmethamphetamineusersintehran
AT khoddamivishtehhamidreza evaluationofbloodleadlevelinmethamphetamineusersintehran